Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Biologics News
Q3-2023 Ophthalmic Revenue Roundup for Roche, Novartis, J&J Vision, and Nicox
Swiss company Roche reported Oct. 19 that Q3-2023 Vabysmo sales were CHF 656 million ($732 million, converted Oct. 19), a 309 percent increase over CHF 173 million in Q3-2022. Vabysmo was approved ...
Syfovre, Acthar Gel Receive J-Codes, While Luminopia Gets A-Code
The Centers for Medicare & Medicaid Services (CMS) issued J-codes in Q2-2023 for Syfovre and Acthar Gel and an A-code for Luminopia’s software for amblyopia treatment. The billing codes take effect...
No Ophthalmic Drugs on List for Medicare Price Negotiation
No ophthalmic pharmaceutical or biologic product made the list of US Medicare Part D drugs subject to price negotiations in 2026. The White House published the list on Aug. 29. Most ophthalmic drug...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.